Sign in
Taking peopleNo phase

Pseudophakic Eyes With Presbyopia-correcting IOLs: OCT Biometry and Pyramid Aberrometry

Key facts

Who runs it
Prim. Prof. Dr. Oliver Findl, MBA
Where
Austria1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
80 people, planned
Started
4 Apr 2024
Planned end
1 Jul 2026
Type of study
Observational, 9 groups
Treatments tested
  • Osiris-T Pyramid Wavefront Sensor - (CSO, Italy)
Record updated
27 February 2026

Who can take part

Age
21 years to 110 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Men and women aged above 21 years with prior uncomplicated cataract/IOL exchange surgery
  • Willing to sign informed consent before measurements
  • Corrected distance visual acuity (CDVA) of 0.1 logMAR or better
  • Absence of corneal scars/dry eye disease that could falsify the light transmission of the study eye
  • Total absence of posterior capsule opacification or patients who already have undergone Nd:YAG capsulotomy
  • Absence of ocular comorbidity (Macular degeneration, glaucoma, amblyopia)

Who cannot take part

  • Prior corneal refractive or ocular surgery
  • Zonular weakness 7) Pseudoexfoliation syndrome 8) Eccentric fixation or insufficient ability to fixate (tremor, nystagmus) 9) Pregnancy
  • Posterior capsule opacification
  • Keratometry between <42.5 and >45 D,
  • Corneal spherical aberration > 0.4 microns 5) Angle kappa > 0.4 mm

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 21 and 110 years old?

This trial is currently available in Austria.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To correlate ocular morphology from anterior segment OCT and pyramid wavefront sensing in order to comprehensively analyze pseudophakic in vivo image quality of presbyopia-correcting IOLs in cataract patients.

The 9 groups in the trial

  • Acrysoft SN60WF (Alcon) - Control

    Aspheric monofocal

    Treatment: Osiris-T Pyramid Wavefront Sensor - (CSO, Italy)

  • Acrysoft IQ Vivity (Alcon)

    Refractive EDOF

    Treatment: Osiris-T Pyramid Wavefront Sensor - (CSO, Italy)

  • AT Lisa Tri (Carl Zeiss Meditec AG)

    Diffractive multifocal

    Treatment: Osiris-T Pyramid Wavefront Sensor - (CSO, Italy)

  • Tecnis Symphony ZXR00 (Johnson & Johnson)

    Diffractive aspheric extended depth of focus

    Treatment: Osiris-T Pyramid Wavefront Sensor - (CSO, Italy)

  • Tecnis Eyhance ICB00 (Johnson & Johnson)

    Enhanced monofocal

    Treatment: Osiris-T Pyramid Wavefront Sensor - (CSO, Italy)

  • RayOne EMV (Rayner Surgical)

    Enhanced monofocal

    Treatment: Osiris-T Pyramid Wavefront Sensor - (CSO, Italy)

  • Acunex Varo AN6V (Teleon Surgical)

    Rotationally asymmetric multifocal extended depth of focus

    Treatment: Osiris-T Pyramid Wavefront Sensor - (CSO, Italy)

  • PureSee (Johnson & Johnson)

    Refractive EDOF

    Treatment: Osiris-T Pyramid Wavefront Sensor - (CSO, Italy)

  • RayOne Trifocal (Rayner)

    Diffractive Multifocal

    Treatment: Osiris-T Pyramid Wavefront Sensor - (CSO, Italy)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Pseudophakic Eyes Implanted With Different Presbyopia-correcting IOL Designs: 3-D Anterior Segment OCT Biometry and Pyramid Wavefront Sensing- Based Retinal Image Quality
Criteria questions
Built from NCT07436247, who can take part
Record updated
27 February 2026